Table 1.
Comparison of patient characteristics and acquired risk factors in patients with mesenteric venous thrombosis versus systemic VTE
| Variable | MVT | Systemic VTE | p value |
|---|---|---|---|
| Number of patients | 120 | 1452 | |
| Median age (IQR); years | 58 (47–70) | 66 (53–76) | < 0.001 |
| Female sex (%) | 53 (44.2) | 739 (50.9) | 0.16 |
| GFR (ml/min) | 93 (74–136) (n = 114) | 67 (52–79) (n = 970) | < 0.001 |
| Platelet count (× 109/L) | 260 (177–340) (n = 112) | 244 (204–299) (n = 1411) | 0.35 |
| Ongoing VTE prophylaxis (%) | 2/116 (1.7) | 30 (2.1) | 0.80 |
| Acquired risk factors (%) | 82/107 (76.6) | 1186/1396 (85.0) | 0.022 |
| Previous venous thromboembolism (any) | 24/120 (20.0) | 203/1451 (14.0) | 0.072 |
| BMI ≥ 30 kg/m2 | 24/88 (27.3) | 296/1364 (21.7) | 0.22 |
| Smoking (ex or current) | 36/103 (35.0) | 771/1346 (57.3) | < 0.001 |
| Surgical intervention (≤ 6 weeks) | 8/117 (6.8) | 207 (14.3) | 0.025 |
| Long travel (≥ 3 h) | 7/117 (6.0) | 102 (7.0) | 0.67 |
| Malignancy (solid cancer) | 23 (19.2) | 176 (12.1) | 0.026 |
| Intra-abdominal malignancy | 20 (16.7) | 33 (2.3) | < 0.001 |
| Hormone therapy (female only) | 7/53 (13.2) | 161/739 (21.8) | 0.14 |
| Pregnancy | 0/53 (0) | 17/739 (2.3) | 0.62 |
| None of these acquired risk factors | 25/107 (23.4) | 210/1396 (15.0) | 0.022 |
| Strong provocative risk factor (recent surgery or malignancy) | 28/119 (23.5) | 356 (24.5) | 0.81 |